Clinical Trial Update: Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)

View source ↗

Summary

A completed clinical trial at CHRU Nancy evaluated Pseudomonas aeruginosa infections in ICU patients with COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Pseudomonas Aeruginosa, COVID-19 | Status: COMPLETED